Table 3.
Cytological, molecular, colposcopic, and histological reports in the two study groups.
| Time 0 months | p value | Time 6 months | p value | Difference % group A | Difference % group B | |||
|---|---|---|---|---|---|---|---|---|
| Group A (N = 358) | Group B (N = 367) | Group A (N = 358) | Group B (N = 367) | |||||
| Pap smear | 0.75 | <0.001 | ||||||
| Negative | 67 (18.7) | 72 (19.6) | 175 (48.9) | 117 (31.9) | ||||
| Positive | 291 (81.3) | 295 (80.4) | 183 (51.1) | 250 (68.1) | -37.1% | -15.2% | ||
| HPV test | 0.55 | <0.001 | ||||||
| Negative | 2 (1.3) | 4 (2.2) | 61 (40.7) | 33 (18.3) | ||||
| Positive | 148 (98.7) | 176 (97.8) | 89 (59.3) | 147 (81.7) | -39.9% | -16.5% | ||
| Colposcopy | ||||||||
| Negative | 64 (17.9) | 66 (18.0) | 0.97 | 212 (59.2) | 145 (39.5) | <0.001 | ||
| Positive | 294 (82.1) | 301 (82.0) | 146 (40.8) | 222 (60.5) | -50.3% | -26.2% | ||
| Biopsy | ||||||||
| Negative | 131 (36.6) | 136 (37.1) | 0.89 | 216 (60.3) | 161 (43.9) | <0.001 | ||
| Positive | 227 (63.4) | 231 (62.9) | 142 (39.7) | 206 (56.1) | -37.4% | -10.8% | ||